Japan's Kishida sends message to shareholders: raise wages
Send a link to a friend
[December 21, 2021] By
Tetsushi Kajimoto and Kiyoshi Takenaka
TOKYO (Reuters) -Japanese Prime Minister
Fumio Kishida on Tuesday called on shareholders to recognise the
importance of raising wages, making a clear push to address one of the
chronic ailments of the world's no.3 economy: low pay.
Kishida also told a news conference that he would compile a policy
package on Dec. 27 to allow small firms to pass on the cost wage hikes,
adding it was important to take every possible step to encourage
companies to raise wages.
After years of deflation, Japanese companies are wary of hiking prices
for fear of losing customers and market share. Instead, they have
typically turned to belt-tightening to keep costs down, leaving them
with razor-thin margins and employees with flat pay.
Kishida, who has called for a "new capitalism", has made low wages one
of his biggest points and called for a redistribution of wealth.
"Paying an appropriate salary provides the foundation of creation of
sustainable corporate value. We need to make large shareholders of a
company understand this point," Kishida said.
Kishida was speaking a day after parliament approved the first extra
budget of the 2021 fiscal year, with record spending of $317 billion.
[to top of second column] |
Japan's Prime Minister Fumio Kishida wearing a protective face mask
delivers his policy speech at the start of an extraordinary session
of the lower house of the parliament, amid the coronavirus disease
(COVID-19) pandemic, in Tokyo, Japan December 6, 2021. REUTERS/Issei
Kato/Files
The 36 trillion yen ($317 billion) budget earmarks funds for tackling
COVID-19, including to secure vaccines and drugs, while it also features
cash payouts for families with children and funds for the promotion of
tourism.
He said Japan's COVID-19 border controls, some of the strictest in the
world, would remain in place for the time being.
Kishida also said he would make arrangements so that Pfizer's
coronavirus oral drugs would be available early next year.
(Reporting by Kiyoshi Takenaka and Tetsushi Kajimoto additional
reporting by Kantaro Komiya and Sakura Murakami; Writing by David Dolan;
Editing by Andrew Heavens and Ed Osmond)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|